209 related articles for article (PubMed ID: 29643467)
1. Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model.
Lee WC; Su CH; Tain YL; Tsai CN; Yu CC; Chuang YC
Sci Rep; 2018 Apr; 8(1):5795. PubMed ID: 29643467
[TBL] [Abstract][Full Text] [Related]
2. Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.
Lee WC; Tain YL; Chuang YC; Tsai CN; Yu CC; Su CH
Neurourol Urodyn; 2019 Nov; 38(8):2159-2169. PubMed ID: 31541501
[TBL] [Abstract][Full Text] [Related]
3. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study.
Kuo HC; Liu HT; Chuang YC; Birder LA; Chancellor MB
Eur Urol; 2014 Jun; 65(6):1117-24. PubMed ID: 24555904
[TBL] [Abstract][Full Text] [Related]
5. Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report.
Ou YL; Liu CY; Cha TL; Wu ST; Tsao CW
Medicine (Baltimore); 2018 Jul; 97(28):e11500. PubMed ID: 29995815
[TBL] [Abstract][Full Text] [Related]
6. Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.
Wang J; Chen Y; Gu D; Zhang G; Chen J; Zhao J; Wu P
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F961-F972. PubMed ID: 28331066
[TBL] [Abstract][Full Text] [Related]
7. What urologists need to know about ketamine-induced uropathy: A systematic review.
Castellani D; Pirola GM; Gubbiotti M; Rubilotta E; Gudaru K; Gregori A; Dellabella M
Neurourol Urodyn; 2020 Apr; 39(4):1049-1062. PubMed ID: 32212278
[TBL] [Abstract][Full Text] [Related]
8. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.
Liu KM; Chuang SM; Long CY; Lee YL; Wang CC; Lu MC; Lin RJ; Lu JH; Jang MY; Wu WJ; Ho WT; Juan YS
Am J Physiol Renal Physiol; 2015 Aug; 309(4):F318-31. PubMed ID: 26109091
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model.
Chueh KS; Huang KH; Lu JH; Juan TJ; Chuang SM; Lin RJ; Lee YC; Long CY; Shen MC; Sun TW; Juan YS
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628581
[TBL] [Abstract][Full Text] [Related]
10. Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
Jhang JF; Hsu YH; Kuo HC
Int J Urol; 2015 Sep; 22(9):816-25. PubMed ID: 26087832
[TBL] [Abstract][Full Text] [Related]
11. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
[TBL] [Abstract][Full Text] [Related]
12. Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure.
Nirmal J; Tyagi P; Chancellor MB; Kaufman J; Anthony M; Chancellor DD; Chen YT; Chuang YC
J Urol; 2013 Apr; 189(4):1553-8. PubMed ID: 23127767
[TBL] [Abstract][Full Text] [Related]
13. Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome.
Liu HT; Chen SH; Chancellor MB; Kuo HC
PLoS One; 2015; 10(8):e0134803. PubMed ID: 26241848
[TBL] [Abstract][Full Text] [Related]
14. [Ketamine-induced vesicopathy].
Lieb M; Bader M; Palm U; Stief CG; Baghai TC
Psychiatr Prax; 2012 Jan; 39(1):43-5. PubMed ID: 22234442
[TBL] [Abstract][Full Text] [Related]
15. Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model.
Lee YL; Lin KL; Chuang SM; Lee YC; Lu MC; Wu BN; Wu WJ; Yuan SF; Ho WT; Juan YS
Am J Pathol; 2017 Sep; 187(9):1945-1959. PubMed ID: 28826558
[TBL] [Abstract][Full Text] [Related]
16. Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.
Rajandram R; Ong TA; Razack AH; MacIver B; Zeidel M; Yu W
Am J Physiol Renal Physiol; 2016 May; 310(9):F885-94. PubMed ID: 26911853
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
Lee CL; Jiang YH; Kuo HC
BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
[TBL] [Abstract][Full Text] [Related]
18. Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model.
Funahashi Y; Yoshida M; Yamamoto T; Majima T; Takai S; Gotoh M
J Urol; 2014 Dec; 192(6):1864-70. PubMed ID: 24992331
[TBL] [Abstract][Full Text] [Related]
19. Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis.
Shao Y; Lu GL; Shen ZJ; He HC
World J Urol; 2013 Jun; 31(3):535-40. PubMed ID: 22358112
[TBL] [Abstract][Full Text] [Related]
20. Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder.
Chuang SM; Liu KM; Li YL; Jang MY; Lee HH; Wu WJ; Chang WC; Levin RM; Juan YS
Neurourol Urodyn; 2013 Nov; 32(8):1137-43. PubMed ID: 23359243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
